AminoChain announced it had raised a $5M seed funding led by a16z crypto with participation from Cercano (family office of Paul Allen).
AminoChain is a16z's first biotech / blockchain investment, and recently completed its CSX accelerator program in London.

AminoChain connects medical institutions and allows developers to build user-owned decentralized healthcare applications. This $5M seed round led by a16z crypto, brings our total funding to date to $7M.

AminoChain is a technology that connects enterprise medical institutions, providing the basis for developers to build user-owned decentralized healthcare applications.